OrthoPediatrics Corp. 8-K Summary
Business Context and Reporting Period
OrthoPediatrics Corp. (Nasdaq: KIDS) filed this Form 8-K on February 26, 2026, to report results of operations and financial condition. The filing references a press release (Exhibit 99.1) containing unaudited condensed consolidated financial statements for the quarter and year ended December 31, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1) and are not detailed in the body of this 8-K document.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the text provided. It serves as a notification that such results and comparisons are available in the attached press release.
Guidance and Outlook
Management provided projections for 2026 regarding revenue, EBITDA, and break-even cash flow in the referenced press release. Specific guidance figures are not included in this filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2025 financial results.
- Verify the 2026 revenue, EBITDA, and break-even cash flow projections mentioned in the press release.
- Confirm the unaudited condensed consolidated financial statements for the period ended December 31, 2025.
- Assess any risks or contingencies disclosed in the accompanying press release.